Migalastat + AT-B101 (Amicus)

N/A

Report date: 2025/02/01 20:00:06

Base Information

Drug NameMigalastat + AT-B101 (Amicus)
Drug Alias NameMigalastat + Human Alpha-Galactosidase A (Amicus)AT-B101/AT-1001
ClassificationBiologics > Protein drugs > Enzyme > Recombinant enzymeBiologics > Protein drugs > Recombinant protein > Recombinant enzyme
Mechanisms of Actionα-Galactosidase stimulants
Targetsα-Galactosidase
Therapy Area/IndicationsFabry Disease
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsYes
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesAmicus Therapeutics Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesAmicus Therapeutics Inc
Active IndicationsN/A
Inactive IndicationsFabry Disease

Other Information

ATC CodeN/A
Related LinksN/A